Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Jan;21(1):e70074.
doi: 10.1111/ijpo.70074.

Components of Adolescent Behavioural Interventions With Eating Disorder Outcomes: Systematic Review With Intervention Mapping

Collaborators, Affiliations

Components of Adolescent Behavioural Interventions With Eating Disorder Outcomes: Systematic Review With Intervention Mapping

Natalie B Lister et al. Pediatr Obes. 2026 Jan.

Abstract

Objective: To understand delivery features and intervention strategies of adolescent weight management interventions which may influence eating disorder risk.

Methods: Systematic searches in four databases and two trial registries to identify randomised controlled trials in adolescents with overweight/obesity measuring eating disorder risk pre- and post-intervention. Delivery features and intervention strategies were coded from published descriptions using a project-specific codebook, validated by trial investigators and narratively synthesised.

Results: Of 11 860 records screened, 23 trials, with 54 intervention arms, were included in the analysis. Most interventions focused on weight loss and maintenance (54%) and were informed by a cognitive behavioural framework (43%). Interventions commonly targeted an individual with a support person (70%). Median intervention duration was 26 weeks, with weekly (35%) or staged (e.g., weekly, then monthly) visit (41%) frequency. Interventions had a mean (SD) of 30 (16.1) intervention strategies. Most included healthy eating education (89%), physical activity education (89%) and problem-solving barriers to dietary change (80%). Few included mental health strategies (17%). Interventions included 'dietary prescription' (65%), and 78% promoted 'healthful/helpful eating behaviours'.

Conclusion: Weight management interventions are complex and vary in delivery approach and strategies used to change behaviors. Characterising interventions is a critical first step to understanding how weight management interventions' influence eating disorder risk.

Keywords: behaviour change techniques; disordered eating; obesity; obesity treatment; overweight.

PubMed Disclaimer

Conflict of interest statement

N.B.L., R.K., I.R.J., S.P., H.M., A.L.S, K.E.H., C.B., S.P.G., S.M., D.N., S.J.P., K.S., K.C., G.D., A.M.G., F.Q., M.R., J.Y., M.K.B., M.P.B., K.N.B., K.E.D., D.M.E., L.H.E., A.B.G., E.J., M.C.L.‐P., T.N., W.L.P., R.I.S., M.T.‐K., A.V.E., B.J.J., H.J. declare no conflicts of interest. A.L.A. is on the Scientific Advisory Board for WW and chairs a Trial Steering Committee for Menwell Ltd. L.A.B. is immediate Past‐President (2022–2024) of the World Obesity Federation, an honorary, unpaid position. She has received honoraria for speaking in forums organised by Novo Nordisk (NN) in relation to management of adolescent obesity (funds directed to research cost centre). L.A.B. is the Australian lead of the study—ACTION Teens: sponsored by NN (multi‐country on‐line study of attitudes towards and perceptions of obesity held by adolescents living with obesity, their parents and health care professionals). L.A.B. has received honoraria (funds directed to hospital research cost centre) for being a member of the Lilly Weight Management Advisory Board. A.J.H. has received payment for advice given to Slimming World (UK). M.K.P. has received travel and consulting fees for speaking and advisory boards from Novo Nordisk, Eli Lilly, Johnson and Johnson Medical Pty Ltd, Takeda Pharmaceuticals and iNova Pharmaceuticals. He was on the guideline development committee for the National Eating Disorder Collaboration ‘Management of eating disorders for people with higher weight: clinical practice guideline (2022)’ and is Vice President of the Australia and New Zealand Obesity Society (ANZOS). A.S. owns 50% of the shares in Zuman International Pty Ltd, which receives royalties and other payments for educational resources and services in adult weight management and research methodology. F.A.N.H. reports serving on the Obesity Society's Finance Committee, consulting fees from WW, an honorarium for speaking from the American Academy of Pediatrics, institutional support to travel and membership on the Obesity Action Coalition's Membership and Access to Care Committees, outside the scope of the submitted work. R.A.J. is an employee and shareholder of WeightWatchers International (WW). T.K.K. has received professional fees from Novo Nordisk, Nutrisystem, Emerald Lake Safety, Roman Health Ventures and Boehringer Ingelheim. M.I.C. is an employee and shareholder of WW International Inc. A.L.D. has an honorary, unpaid position at Nutrition Society of Australia as Honorary Secretary and Director of the Board from 2024. H.F.S. previously received salary from Novo Nordisk unrelated to the present work. Y.S.D. received a one‐time payment from NovoNordisk for creating information materials about eating disorders for health care professionals. Y.S.D. is part of the steering group of the E‐BATTLE Obesity trial a placebo‐controlled RCT testing semaglutide in the treatment of severe obesity in adolescents (starting in 2025). Medications and placebo‐medications are provided by Novo Nordisk but not funding for the study. A.P.V. has received consulting fees from Rhythm Pharmaceuticals and Soleno Pharmaceuticals. J.A.Y. reports unrelated grant funds to NICHD supporting his clinical research from Soleno Therapeutics, Rhythm Pharmaceuticals and Hikma Pharmaceuticals and materials from Versanis Bio to support mouse studies.

Figures

FIGURE 1
FIGURE 1
PRISMA flow diagram.
FIGURE 2
FIGURE 2
Frequency of intervention strategies across and within intervention arms. Each row represents an intervention arm arranged by year of the corresponding trial, starting from the oldest trial at the top down to the most recent trial (based on recruitment date, or publication date if unavailable). Each column represents clusters of intervention strategies within five broad categories; each number in brackets reports the number of strategies within that cluster. The colors of each square depict the proportion of total intervention strategies within that strategy cluster that are used in the intervention arm.
FIGURE 3
FIGURE 3
Frequency of individual and combinations of intervention strategy clusters across all interventions. Circles represent clusters of intervention strategy clusters with circle colours corresponding to category levels. Frequency of intervention strategy clusters is reflected by circle sizes with larger circles representing more common strategy clusters. Combinations and frequency strategy clusters are reflected by line width and connections, with thicker lines representing more common combinations.

References

    1. Hampl S. E., Hassink S. G., Skinner A. C., et al., “Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity,” Pediatrics 151, no. 2 (2023): e2022060640, 10.1542/peds.2022-060640. - DOI - PubMed
    1. Lister N. B., Baur L. A., Felix J. F., et al., “Child and Adolescent Obesity,” Nature Reviews Disease Primers 9, no. 1 (2023): 24, 10.1038/s41572-023-00435-4. - DOI - PubMed
    1. Al‐shoaibi A. A. A., Lavender J. M., Kim S. J., et al., “Association of Body Mass Index With Progression From Binge‐Eating Behavior Into Binge‐Eating Disorder Among Adolescents in the United States: A Prospective Analysis of Pooled Data,” Appetite 200 (2024): 107419, 10.1016/j.appet.2024.107419. - DOI - PMC - PubMed
    1. Khalid R., Lister N. B., Paxton S. J., et al., “Potential Pathways to the Onset and Development of Eating Disorders in People With Overweight and Obesity: A Scoping Review,” Obesity Reviews 26, no. 1 (2025): e13840, 10.1111/obr.13840. - DOI - PMC - PubMed
    1. Lister N. B., Baur L. A., Paxton S. J., and Jebeile H., “Contextualising Eating Disorder Concerns for Paediatric Obesity Treatment,” Current Obesity Reports 10, no. 3 (2021): 322–331, 10.1007/s13679-021-00440-2. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources